This is a Validated Antibody Database (VAD) review about rabbit ETS1, based on 3 published articles (read how Labome selects the articles), using ETS1 antibody in all methods. It is aimed to help Labome visitors find the most suited ETS1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ETS1 synonym: c-ets-1; c-ets1; protein C-ets-1; v-ets erythroblastosis virus E26 oncogene homolog 1

Invitrogen
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat
  • western blot; rat
In order to study the role of ETS-1 in Dahl salt-sensitive rats, Invitrogen ETS1 antibody (Invitrogen, 44-1104G) was used in immunohistochemistry - paraffin section on rat samples and in western blot on rat samples . Hypertension (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 1
In order to examine how DUSP4 regulates the MAP-ERK kinase and c-jun-NH2-kinase pathways in modifying cancer stem cell-like behavior, Invitrogen ETS1 antibody (Invitrogen, 44-1104G) was used in western blot on human samples (fig 1). Cancer Res (2013) ncbi
rabbit polyclonal
  • western blot; human; 1:500; fig 4
In order to identify genes associated with neoadjuvant chemotherapy resistance, Invitrogen ETS1 antibody (Invitrogen, 44-1104G) was used in western blot on human samples at 1:500 (fig 4). Nat Med (2012) ncbi
Articles Reviewed
  1. Feng W, Chumley P, Prieto M, Miyada K, Seth D, Fatima H, et al. Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension. Hypertension. 2015;65:813-20 pubmed publisher
  2. Balko J, Schwarz L, Bhola N, Kurupi R, Owens P, Miller T, et al. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. Cancer Res. 2013;73:6346-58 pubmed publisher
  3. Balko J, Cook R, Vaught D, Kuba M, Miller T, Bhola N, et al. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat Med. 2012;18:1052-9 pubmed publisher